Table 1.
Patient characteristics (N = 10) and tumor parameters (N = 11)
| Characteristic | |
|---|---|
| BMI, median (range), kg/m2 | 25.5 (22.8, 35.5) |
| Smoking status, n (%) | |
| Current smoker | 3 (30) |
| Former smoker | 6 (60) |
| Nonsmoker | 1 (10) |
| Radiation history, n (%) | |
| Yes | 1 (10) |
| No | 9 (90) |
| Comorbidities, n (%) | |
| Hypertension | 8 (80) |
| Hyperlipidemia/hypercholesterolemia | 8 (80) |
| Gastroesophageal reflux disease | 5 (50) |
| Depression | 4 (40) |
| COPD/emphysema | 3 (30) |
| Cerebrovascular accident | 2 (20) |
| Myocardial infarction/coronary artery disease | 2 (20) |
| Hypothyroidism | 2 (20) |
| ECOG performance score, median (range) | 1 (0, 2) |
| Pulmonary function, median (range) | |
| FEV1, mL | 1,910 (850, 2,910) |
| FEV1, % predicted | 78 (52, 126) |
| FVC, mL | 2,905 (1,270, 4,460) |
| FVC, % predicted | 84 (55, 121) |
| FEV/FVC | 71.5 (47, 97) |
| TLC, mL | 5,435 (3,560, 6,670) |
| TLC, % predicted | 90.5 (73, 107) |
| FRC, mL | 2,870 (1,820, 4,390) |
| FRC, % predicted | 103.5 (74, 135) |
| DLCO, mL/min/mm Hg | 13.45 (4.1, 27.9) |
| DLCO, % predicted | 61.5 (29, 125) |
| Tumor type, n (%) | |
| NSCLC (medically inoperable) | 4 (36) |
| NSCLC (medically operable; declined surgery) | 6 (55) |
| Other (“carcinoid, medically operable; declined surgery”) | 1 (9) |
| Tumor sub-type, n (%) | |
| Squamous cell carcinoma | 4 (36) |
| Adenocarcinoma | 5 (45) |
| Large cell carcinoma | 0 (0) |
| Other (“carcinoid,” “poorly differentiated non-small cell carcinoma”) | 2 (18) |
| Tumor location, n (%) | |
| Right upper lobe (RUL) | 4 (36) |
| Right middle lobe (RML) | 0 (0) |
| Right lower lobe (RLL) | 2 (18) |
| Left upper lobe (LUL) | 2 (18) |
| Left lower lobe (LLL) | 2 (18) |
| Other (“superior segment of the RLL”) | 1 (9) |
| Distance from pleura, median (range), mm | 18 (10, 39) |
| Largest diameter, median (range), mm | 14 (7, 19) |
| Smallest diameter, median (range), mm | 13 (7, 19) |